Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2524-2023Class II

Magnifuse Bone Graft, Large, Size: 14mm x 25mm, REF 7509014, Human Tissue, Demineralized Bone Matrix, sterile

Medtronic Sofamor Danek USA Inc / initiated 2023-07-31 / Open, Classified / root cause: manufacturing process

Medtronic Sofamor Danek USA Inc began a recall of Magnifuse Bone Graft, Large, Size: 14mm x 25mm, REF 7509014, Human Tissue, Demineralized Bone Matrix, sterile on . FDA classified it as Class II and gives the reason as "The incorrect product labeling was applied to the product indicating the wrong size of product". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-2524-2023
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Medtronic Sofamor Danek USA Inc
Product
Magnifuse Bone Graft, Large, Size: 14mm x 25mm, REF 7509014, Human Tissue, Demineralized Bone Matrix, sterile.
Product code
MQV Filler, Bone Void, Calcium Compound
Reason for recall
The incorrect product labeling was applied to the product indicating the wrong size of product.
Root cause tag
manufacturing process
FDA root cause
Process control
Action
Beginning 7/31/2023, In the U.S. Medtronic initiated a Consignee Notification and Customer Confirmation Form via UPS 2-Day delivery to each listed consignee. Consignees were asked to quarantine and return any affected unused product they may have and complete and return the Customer Confirmation Form (i.e. reply form). Additionally, consignees were asked to forward this notification to those who need to be aware within the organization or to any location which the devices have been transferred.
Quantity in commerce
55 pouches
Distribution
US Nationwide distribution in the states of ID, IN, MN, NC, NY, OH, OR, WA, and WI.
Product codes and lots
Serial numbers: A57958-011, A57958-012, A57958-013, A57958-014, A57958-015, A57958-016, A57958-017, A57958-018, A57958-019, A57958-020, A57958-021, A57958-022, A57958-023, A57958-024, A57958-025, A57958-026, A57958-027, A57958-028, A57958-029, A57958-030, A57958-031, A57958-033, A57958-034, A57958-035, A57958-036, A57958-037, A57958-038, A57958-048, A57958-050, A57958-051, A57958-052, A57958-053, A57958-054, A57958-055, A57958-056, A57958-057, A57958-058, A57958-059, A57958-060, A57958-066, A57958-069, A57958-070, A57958-072, A57958-073, A57958-074, A57958-075, A57958-076, A57958-077, A57958-078, A57958-079, A57958-080, A57958-081, A57958-082, A57958-085, A57958- 086. Exp. 2/15/2025. UDI-DI 00613994986467

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2524-2023
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2524-2023Class IIOngoingVoluntary: Firm initiated